-+ 0.00%
-+ 0.00%
-+ 0.00%

Medtronic wins FDA breakthrough device tag for Sphere-9 ventricular arrhythmia catheter

PUBT·08/06/2026 11:12:51
Listen to the news
Medtronic wins FDA breakthrough device tag for Sphere-9 ventricular arrhythmia catheter
  • Medtronic received FDA Breakthrough Device Designation for its Sphere-9 catheter to treat ventricular arrhythmias.
  • The designation supports an expedited US regulatory pathway as the Sphere VT pivotal trial begins enrolling patients.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.